Predictive Factors for Anastomotic Leakage After Colorectal Surgery (REVEAL)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02347735 |
Recruitment Status :
Completed
First Posted : January 27, 2015
Last Update Posted : September 29, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Rationale: Colorectal cancer is the fourth most common cause of cancer death worldwide, estimated to be responsible for almost 610,000 deaths in 2008. Surgery remains the predominant curative treatment type for colorectal cancer, but has a major impact on the patient's wellbeing by demanding large amounts of metabolic reserves. This can lead to the development of frequently observed and severe postoperative complications. The most important complication after colorectal surgery is anastomotic leakage (AL), which has an incidence of 8-15% in the Netherlands. AL is associated with high short-term mortality rates of up to 40%. Even though many attempts have been made to reduce the incidence of this dreaded complication, none of these interventions have been successful so far. Despite proper patient selection and improvement in surgical techniques, the percentage of AL has been stable for years.
Objectives: To investigate whether recently identified patient-specific factors can predict the occurrence of anastomotic leakage in patients undergoing elective surgery for colorectal cancer.
Study design: Prospective observational study Study population: Adult colorectal cancer patients undergoing elective surgery. Main study parameters/endpoints: Primary endpoint: AL within 30 days postoperatively Secondary endpoints: Intestinal microbiome in fecal sample, I-FABP, SM22, Calprotectin, C-reactive protein(CRP), Citrullin, complement factors in blood, VOCs in exhaled air, COX-2 & MBL polymorphisms in buccal smear, L3-index & atherosclerosis measurements on CT-scans, SNAQ & MUST scores
Condition or disease | Intervention/treatment |
---|---|
Anastomotic Leakage Colorectal Cancer Anastomotic Leak Colorectal Neoplasms Colorectal Carcinoma Colorectal Tumors | Other: No interventions, only data collection |

Study Type : | Observational |
Actual Enrollment : | 774 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Predictive Factors for Anastomotic Leakage After Colorectal Surgery: The REVEAL Study |
Study Start Date : | August 2015 |
Actual Primary Completion Date : | July 1, 2021 |
Actual Study Completion Date : | July 1, 2021 |
Group/Cohort | Intervention/treatment |
---|---|
Anastomotic leakage
Of the entire cohort, data collected from patients suffering from anastomotic leakage will be evaluated and compared to patients that did not develop anastomotic leakage. No interventions, only data collection.
|
Other: No interventions, only data collection
Only data is collected from the subjects in both groups. |
No anastomotic leakage
Of the entire cohort, data collected from patients suffering from anastomotic leakage will be evaluated and compared to patients that did not develop anastomotic leakage. No interventions, only data collection.
|
Other: No interventions, only data collection
Only data is collected from the subjects in both groups. |
- Anastomotic leakage [ Time Frame: within 30 days ]
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- in need of laparoscopic or open large bowel resection with primary anastomosis as standard treatment for colorectal carcinoma
Exclusion Criteria:
- not requiring an anastomosis
- abdominal surgery in the past 4 weeks (with exception from temporary defunctioning ostomies for patients with obstructive colorectal tumours)
- pregnancy
- cognitively impaired

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02347735
Netherlands | |
Zuyderland Medical Centre | |
Heerlen, Netherlands | |
Maastricht University Medical Centre | |
Maastricht, Netherlands | |
Zuyderland Medical Centre | |
Sittard, Netherlands | |
VieCuri Medical Centre | |
Venlo, Netherlands |
Principal Investigator: | Nicole Bouvy, MD, PhD | Maastricht University Medical Centre |
Responsible Party: | Maastricht University Medical Center |
ClinicalTrials.gov Identifier: | NCT02347735 |
Other Study ID Numbers: |
METC142073 |
First Posted: | January 27, 2015 Key Record Dates |
Last Update Posted: | September 29, 2021 |
Last Verified: | March 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Colorectal carcinoma Anastomotic leakage Markers Diagnosis |
Colorectal Neoplasms Anastomotic Leak Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases Postoperative Complications Pathologic Processes |